(Q34808260)

4 August 2017

title

Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries (English)

1 reference

4 August 2017

Elisabetta Poluzzi

2

0 references

Fabrizio De Ponti

object named as

Fabrizio De Ponti

1

0 references

Ulf Bergman

4

object named as

Ulf Bergman

1 reference

4 August 2017

Alberto Vaccheri

3

1 reference

4 August 2017

Lars Bjerrum

5

1 reference

4 August 2017

John Ferguson

6

1 reference

4 August 2017

Kerry J Frenz

7

1 reference

4 August 2017

Peter McManus

8

1 reference

4 August 2017

Ingrid Schubert

9

1 reference

4 August 2017

Gisbert Selke

10

1 reference

4 August 2017

Georgia Terzis-Vaslamatzis

11

1 reference

4 August 2017

Nicola Montanaro

12

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

British Journal of Clinical Pharmacology

4 August 2017

published in

1 reference

4 August 2017

volume

54

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

171-177

1 reference

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Drug-induced proarrhythmic effects: assessment of changes in QT interval

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Drug-induced torsade de pointes: from molecular biology to bedside.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Cardiotoxic potential and CNS effects of first-generation antihistamines.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

QT lengthening and life-threatening arrhythmias associated with fexofenadine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

QT interval: a measure of drug action

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

QT prolongation in type 2 diabetes mellitus treated with glibenclamide.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01617.X

The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01617.X

Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01617.X

Recent trends in the use of antidepressant drugs in Australia, 1990-1998.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

QT lengthening and life-threatening arrhythmias associated with fexofenadine

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874396

Fexofenadine-induced QT prolongation: a myth or fact?

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12207637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12207637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sulfonylureas blockade of neural and cardiac HERG channels

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12207637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2125.2002.01617.X

1 reference

4 August 2017

1 reference

4 August 2017

1 reference